New meningitis vaccine proves promising in defeating epidemic
Pentavalent vaccine was found effective against five of the six meningococcal bacteria strains found in Africa.
Stay updated with breaking news from Immunity Theme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pentavalent vaccine was found effective against five of the six meningococcal bacteria strains found in Africa.
A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal bacteria: A, C, W, Y and X. The phase 3 trial compared the immune response generated by the new pentavalent vaccine NmCV-5 against that of the licensed quadrivalent MenACWY-D vaccine in 1,800 healthy 2-29-year-olds in Mali and The Gambia.
A trial investigating a new vaccine targeting meningococcal disease, a leading cause of meningitis and blood poisoning, has concluded that the vaccine is
A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal bacteria: A, C, W, Y and X.
The third day of World Immunisation Week will concentrate on Tuberculosis, focusing on vaccine development, progress, equity and clinical trials. The webinar, chaired by Toyin Togun from LSHTM, will include a presentation by Jayne Sutherland from LSHTM on TB vaccine development and Richard White from LSHTM on the contribution of TB vaccines to global TB control.